EudraLex

Results: 263



#Item
2217th May[removed]Contribution from Groupement des Pharmaciens de L’Industrie en Europe (European Industrial Pharmacists’ Group), to the Public Consultation in Preparation of a legal proposal to combat Counterfeit Medici

7th May[removed]Contribution from Groupement des Pharmaciens de L’Industrie en Europe (European Industrial Pharmacists’ Group), to the Public Consultation in Preparation of a legal proposal to combat Counterfeit Medici

Add to Reading List

Source URL: ec.europa.eu

Language: English - Date: 2013-10-09 09:46:45
222Commission Guideline — Guidance on posting and publication of result-related information on clinical trials in relation to the implementation of Article[removed]of Regulation (EC) No[removed]and Article[removed]of Regulat

Commission Guideline — Guidance on posting and publication of result-related information on clinical trials in relation to the implementation of Article[removed]of Regulation (EC) No[removed]and Article[removed]of Regulat

Add to Reading List

Source URL: ec.europa.eu

Language: English - Date: 2013-10-09 09:02:34
223John Dalli Member of the European Commission, responsible for Health and Consumer Policy Commissioner Dalli delivers speech on

John Dalli Member of the European Commission, responsible for Health and Consumer Policy Commissioner Dalli delivers speech on "Clinical Trials Directive – Meeting

Add to Reading List

Source URL: ec.europa.eu

Language: English - Date: 2012-03-08 08:36:32
224[removed]EUROGROUP FOR ANIMALS  PHARMACEUTICALS Current situation The pharmaceutical sector is extensively regulated at the European Union’s level in the dual interest of ensuring the highest possible level of public h

[removed]EUROGROUP FOR ANIMALS PHARMACEUTICALS Current situation The pharmaceutical sector is extensively regulated at the European Union’s level in the dual interest of ensuring the highest possible level of public h

Add to Reading List

Source URL: eurogroupforanimals.org

Language: English - Date: 2011-09-06 07:17:01
225Microsoft Word - 2008_03_11_Consultation Document FINAL _public_.doc

Microsoft Word - 2008_03_11_Consultation Document FINAL _public_.doc

Add to Reading List

Source URL: ec.europa.eu

Language: English - Date: 2013-10-09 09:25:50
226What you Need to Know about  Biosimilar Medicinal Products

What you Need to Know about Biosimilar Medicinal Products

Add to Reading List

Source URL: ec.europa.eu

Language: English - Date: 2013-04-22 02:55:35
227Proposal for revision of guideline_Track changes March 2012

Proposal for revision of guideline_Track changes March 2012

Add to Reading List

Source URL: ec.europa.eu

Language: English - Date: 2013-10-09 09:02:33
228EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL Health systems and products Medicinal products – quality, safety and efficacy  Implementation

EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL Health systems and products Medicinal products – quality, safety and efficacy Implementation

Add to Reading List

Source URL: ec.europa.eu

Language: English - Date: 2014-03-28 08:54:56
229Research / Health / Pharmacology / European Union / Pharmaceutical industry / European Medicines Agency / Supplementary protection certificate / EudraLex / Clinical Trials Directive / Clinical research / Pharmaceuticals policy / Pharmaceutical sciences

Guidelines on the details of the various categories of variations, on the operation of the procedures laid down in Chapters II, IIa, III and IV of Commission Regulation (EC) No[removed]of 24 November 2008 concerning t

Add to Reading List

Source URL: ec.europa.eu

Language: English - Date: 2013-10-09 08:55:16
230Brussels, xx December 2009 F2/2009/D/2102

Brussels, xx December 2009 F2/2009/D/2102

Add to Reading List

Source URL: ec.europa.eu

Language: English - Date: 2013-10-09 08:56:16